Allogeneic and xenogeneic hepatocyte transplantation in experimental hepatic failure

Transplantation
L MakowkaM J Phillips

Abstract

Previous studies have demonstrated the efficacy of syngeneic hepatocyte transplantation in the treatment of D-galactosamine-induced acute hepatic failure in Lewis strain rats. This report describes the efficacy and immunological consequences of allogeneic and xenogeneic hepatocyte transplantation in the same model. The i.p. administration of allogeneic (minor and major histoincompatibility) hepatocytes or xenogeneic (rabbit or porcine) hepatocytes at a dose of 4 x 10(7) cells/rat given at 48 hr after toxin all resulted in significant improvement in survival compared to that of controls, and also comparable to the results obtained with syngeneic hepatocyte transplantation. Sensitization to i.p. allogeneic (WF) hepatocyte administration was demonstrated by in vivo 51Cr release, indirect immunofluorescent technique, and accelerated skin allograft rejection. Similarly, the in vivo 51Cr release assay was able to detect sensitization to porcine hepatocytes. Despite evidence of immunogenicity, redosing with either WF or porcine hepatocytes resulted in no overt toxicity. Furthermore, presensitization by either WF hepatocytes or skin allografts did not adversely affect survival after WF hepatocyte treatment in D-galactosamine-induced he...Continue Reading

Citations

Nov 1, 1986·The Japanese Journal of Surgery·M SawaM Mito
Dec 27, 2008·Journal of Hepato-biliary-pancreatic Surgery·Masahiro ItoIra J Fox
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F D LedleyS L Woo
Jan 1, 1994·Transplant International : Official Journal of the European Society for Organ Transplantation·M R SchönP Neuhaus
Feb 14, 2009·Journal of Gastroenterology·Sei KakinumaMamoru Watanabe
Nov 1, 1995·Biopharmaceutics & Drug Disposition·M GaltierF Bressolle
Dec 1, 1987·Journal of Pediatric Surgery·M W FlyeS Yu
Mar 30, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Marc H DahlkeJohn E J Rasko
Jul 20, 2010·Xenotransplantation·André Gustavo BonavitaLuiz Anastácio Alves
Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G L BumgardnerD E Sutherland
May 8, 2015·Xenotransplantation·Huidong ZhouDavid K C Cooper
Dec 7, 2010·Trends in Biotechnology·Abhishek AnanthanarayananHanry Yu
Apr 29, 2015·Journal of Hepatology·Stuart J ForbesAnil Dhawan
Jun 3, 2010·The Journal of International Medical Research·D LytrasC E Simopoulos
Jan 1, 2010·Cell Medicine·Luiz Anastácio AlvesRoberto Magalhães Saraiva
Sep 1, 1985·The Journal of Surgical Research·J P VroemenG Kootstra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.